Cargando…

UK Biobank: opportunities for cardiovascular research

Detalles Bibliográficos
Autores principales:	Littlejohns, Thomas J, Sudlow, Cathie, Allen, Naomi E, Collins, Rory
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Current Opinion
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6451771/ https://www.ncbi.nlm.nih.gov/pubmed/28531320 http://dx.doi.org/10.1093/eurheartj/ehx254

Ejemplares similares

Comparison of Sociodemographic and Health-Related Characteristics of UK Biobank Participants With Those of the General Population
por: Fry, Anna, et al.
Publicado: (2017)

The advantages of UK Biobank's open‐access strategy for health research
por: Conroy, M., et al.
Publicado: (2019)

Challenges of linking to routine healthcare records in UK Biobank
por: Adamska, Ligia, et al.
Publicado: (2015)

Association between coeliac disease and cardiovascular disease: prospective analysis of UK Biobank data
por: Conroy, Megan, et al.
Publicado: (2023)

Developing automated methods for disease subtyping in UK Biobank: an exemplar study on stroke
por: Rannikmäe, Kristiina, et al.
Publicado: (2021)

Lifestyle factors and prostate-specific antigen (PSA) testing in UK Biobank: Implications for epidemiological research
por: Littlejohns, Thomas J., et al.
Publicado: (2016)

Algorithms for the Capture and Adjudication of Prevalent and Incident Diabetes in UK Biobank
por: Eastwood, Sophie V, et al.
Publicado: (2016)

New Horizons: the value of UK Biobank to research on endocrine and metabolic disorders
por: Bešević, Jelena, et al.
Publicado: (2022)

Cohort profile: design and methods in the eye and vision consortium of UK Biobank
por: Chua, Sharon Yu Lin, et al.
Publicado: (2019)

Reproducible disease phenotyping at scale: Example of coronary artery disease in UK Biobank
por: Patel, Riyaz S., et al.
Publicado: (2022)

A Window of Opportunity for Newborn Screening
por: Bailey Jr, Donald B.
Publicado: (2022)

Human Cytomegalovirus and Risk of Incident Cardiovascular Disease in United Kingdom Biobank
por: Hamilton, Elizabeth M, et al.
Publicado: (2021)

Medicines Regulation in Africa: Current State and Opportunities
por: Ndomondo-Sigonda, Margareth, et al.
Publicado: (2017)

Malaria and Economic Evaluation Methods: Challenges and Opportunities
por: Drake, Tom L., et al.
Publicado: (2017)

The UK Biobank imaging enhancement of 100,000 participants: rationale, data collection, management and future directions
por: Littlejohns, Thomas J., et al.
Publicado: (2020)

The Challenges and Opportunities Associated with Reimbursement for Obesity Pharmacotherapy in the USA
por: Baum, Charles, et al.
Publicado: (2015)

Accuracy of Patient Self-Report of Stroke: A Systematic Review from the UK Biobank Stroke Outcomes Group
por: Woodfield, Rebecca, et al.
Publicado: (2015)

Factors associated with potentially serious incidental findings and with serious final diagnoses on multi-modal imaging in the UK Biobank Imaging Study: A prospective cohort study
por: Gibson, Lorna M., et al.
Publicado: (2019)

UK Biobank: a globally important resource for cancer research
por: Conroy, Megan C., et al.
Publicado: (2022)

Acquiring Pharmaceutical Industry Assets in the UK: 1 + 1 = 1?
por: Kanavos, Panos, et al.
Publicado: (2014)

Identification of host–pathogen-disease relationships using a scalable multiplex serology platform in UK Biobank
por: Mentzer, Alexander J., et al.
Publicado: (2022)

Cardiovascular Risk with Non-steroidal Anti-inflammatory Drugs: Clinical Implications
por: Bello, Alfonso E., et al.
Publicado: (2014)

Power of mentorship for civilian and military acute care surgeons: identifying and leveraging opportunities for longitudinal professional development
por: Knowlton, Lisa Marie, et al.
Publicado: (2023)

Global position paper on cardiovascular regenerative medicine
por: Fernández-Avilés, Francisco, et al.
Publicado: (2017)

Real-World Monitoring of COVID-19 Vaccines: An Industry Expert View on the Successes, Challenges, and Future Opportunities
por: Bauchau, Vincent, et al.
Publicado: (2023)

Evidence-Based Medicine and Healthcare Quality in the Context of Information Failure: The Case of the UK Fertility Sector
por: Zhu, Minyan
Publicado: (2021)

Using Economics to Impact Local Obesity Policy: Introducing the UK Centre for Economics of Obesity (CEO)
por: Frew, Emma, et al.
Publicado: (2022)

UK Biobank: An Open Access Resource for Identifying the Causes of a Wide Range of Complex Diseases of Middle and Old Age
por: Sudlow, Cathie, et al.
Publicado: (2015)

Translational research: turning research into advocacy
por: Dechert, Tracey
Publicado: (2019)

Allocating Public Spending Efficiently: Is There a Need for a Better Mechanism to Inform Decisions in the UK and Elsewhere?
por: Cubi-Molla, Patricia, et al.
Publicado: (2021)

UK Biobank’s cardiovascular magnetic resonance protocol
por: Petersen, Steffen E., et al.
Publicado: (2016)

Towards a more efficient healthcare system: Opportunities and challenges caused by hospital closures amid the COVID-19 pandemic
por: Saghafian, Soroush, et al.
Publicado: (2022)

Clinical and Regulatory Challenges and Opportunities for Monoclonal Antibodies in Low- and Middle-Income Countries: Lessons from COVID-19 and Beyond
por: Gieber, Lisa, et al.
Publicado: (2023)

Revision of Ireland’s Cost-Effectiveness Threshold: New State-Industry Drug Pricing Deal Should Adequately Reflect Opportunity Costs
por: O’Mahony, James F.
Publicado: (2021)

The continuum of personalized cardiovascular medicine: a position paper of the European Society of Cardiology
por: Kirchhof, Paulus, et al.
Publicado: (2014)

Cardiovascular Safety Profile of Dapoxetine during the Premarketing Evaluation
por: Kowey, Peter R., et al.
Publicado: (2012)

Living myocardial slices: a novel multicellular model for cardiac translational research
por: Perbellini, Filippo, et al.
Publicado: (2020)

Are the Current Processes and Regulations Fit for Purpose to Deliver Novel Therapies During Pandemics? A Perspective on COVID-19 from the UK
por: Jandu, Rajmeet, et al.
Publicado: (2022)

Profound reductions in first and total cardiovascular events with icosapent ethyl in the REDUCE-IT trial: why these results usher in a new era in dyslipidaemia therapeutics
por: Boden, William E, et al.
Publicado: (2020)

Blood-Based Biomarkers for Managing Workload in Athletes: Perspectives for Research on Emerging Biomarkers
por: Haller, Nils, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_4r9aumvs8l5lfj57104acmvs3m